LT beta R

Lymphotoxin-beta receptor (LTβR, TNFRSF3) is a TNF receptor superfamily member that functions as the master regulator of secondary lymphoid organogenesis and mucosal immunity. LTβR is a type I transmembrane protein with four cysteine-rich domains, expressed on stromal organizer cells, follicular dendritic cells, high endothelial venules, epithelial cells, myeloid cells and hepatocytes. Its ligands are membrane-bound heterotrimers: lymphotoxin-α1β2 (LTα1β2) on lymphoid tissue inducer cells, B cells and activated T cells, and LIGHT (TNFSF14). Ligand engagement activates both canonical and non-canonical NF-κB pathways through TRAF2/TRAF3-NIK signaling cascades, inducing chemokines (CXCL13, CCL19, CCL21), adhesion molecules (MAdCAM-1, VCAM-1) and homeostatic cytokines that organize lymph node, spleen and Peyer's patch architecture. LTβR signaling additionally drives intestinal epithelial innate immunity (including Paneth cell and defensin programs), hepatic acute-phase responses and osteoclastogenesis; LTβR blockade is clinically validated (etracleotide approaches) in autoimmune inflammation and explored in lymphoid cancers.